RecruitingNCT05022914
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Prostate-Specific Membrane Antigen (PSMA) Guided Approach for bIoCHEmical Relapse After Prostatectomy- A Prospective Observational Study-PSICHE
Sponsor
Azienda Ospedaliero-Universitaria Careggi
Enrollment
180 participants
Start Date
Jan 19, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria3
- Signed informed consent
- Age \>18
- Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1
Exclusion Criteria2
- ADT administration within 6 months from study enrollment
- Persistent elevation of PSA after RP measured within 16 weeks from surgery (\> 0.1 ng/ml)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05022914
Related Trials
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
NCT060228225 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location